Quick Answer
Twist Bioscience Corp reported Common Stock Shares Outstanding of 60.63 million shares for the year ending 2025.
- Twist Bioscience Corp showed an increase of +3.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Twist Bioscience Corp's annual report (Form 10-K), filed with the SEC on November 17, 2025.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2018: 28.01 million shares | Q1 2019: 28.02 million shares | Q2 2019: 32.47 million shares | Q4 2019: 33.26 million shares | Q1 2020: 40.97 million shares | Q2 2020: 44.62 million shares | Q4 2020: 48.62 million shares | Q1 2021: 48.86 million shares | Q2 2021: 49.26 million shares | Q4 2021: 50.74 million shares | Q1 2022: 56.23 million shares | Q2 2022: 56.34 million shares | Q4 2022: 56.65 million shares | Q1 2023: 57.11 million shares | Q2 2023: 57.37 million shares | Q4 2023: 57.78 million shares | Q1 2024: 58.16 million shares | Q2 2024: 58.52 million shares | Q4 2024: 59.58 million shares | Q1 2025: 59.86 million shares | Q2 2025: 60.17 million shares | Q3 2025: 60.63 million shares | Q4 2025: 61.27 million shares.
- Over the full 8 years of available data (2018 to 2025), Twist Bioscience Corp's Common Stock Shares Outstanding has grown by 1,791.1%.
- Historical annual values: Fiscal year 2025: 60.63 million shares | Fiscal year 2024: 58.88 million shares | Fiscal year 2023: 57.56 million shares | Fiscal year 2022: 56.52 million shares | Fiscal year 2021: 49.50 million shares | Fiscal year 2020: 45.08 million shares | Fiscal year 2019: 32.87 million shares | Fiscal year 2018: 3.21 million shares.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: